Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy
Open Access
- 1 August 2009
- journal article
- review article
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. 1, 105-111
Abstract
Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine, Philadelphia, USA; 3Southern California Center for Sexual Health and Survivorship Medicine, Newport Beach, CA, USA Vulvovaginal atrophy (VVA) and dryness are common symptoms of the decline in endogenous production of estrogen at menopause and often result in dyspareunia. Yet while 10% to 40% of women experience discomfort due to VVA, it is estimated that only 25% seek medical help. The main goals of treatment for vaginal atrophy are to improve symptoms and to restore vaginal and vulvar anatomic changes. Treatment choices for postmenopausal dyspareunia resulting from vulvovaginal atrophy will depend on the underlying etiology and might include individualized treatment. A number of forms of vaginal estrogen and manner of delivery are currently available to treat moderate to severe dyspareunia caused by VVA. They all have been shown to be effective and are often the preferred treatment due to the targeted efficacy for urogenital tissues while resulting in only minimal systemic absorption. Both healthcare professionals and patients often find it difficult to broach the subject of sexual problems associated with VVA. However, with minimal effort to initiate a conversation about these problems, healthcare providers can provide useful information to their postmenopausal patients in order to help them each choose the optimal treatment for their needs and symptoms.Keywords: dyspareunia, postmenopausal vulvovaginal atrophy, vaginal estrogen therapyKeywords
This publication has 24 references indexed in Scilit:
- Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginallyMenopause, 2009
- Approach to the Patient with Menopausal SymptomsThe Journal of Clinical Endocrinology & Metabolism, 2008
- Vulvovaginal ComplaintsClinical Obstetrics and Gynecology, 2008
- By the way, doctor. My doctor prescribed a low-dose vaginal estrogen cream, applied twice a week, for atrophic vaginitis. I've heard this dose is so low that it carries no health risk. Do you agree?2007
- The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal womenMenopause, 2007
- Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tabletClimacteric, 2005
- Local oestrogen for vaginal atrophy in postmenopausal women2003
- Urogenital atrophy. A new approach to vaginitis diagnosis.2002
- Women's perceptions and concerns about menopause.1998
- Decision making in support: Patient perceptions and preferencesJournal of Clinical Epidemiology, 1990